shRNA Library Design for Gene Suppression Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering short hairpin RNA (shRNA) into mammalian cells for gene suppression are limited in variability and efficiency, particularly in generating libraries of nucleic acid vectors that can effectively target specific mRNA sequences.
Innovation Solution
A library of nucleic acid vectors comprising nucleic acid molecules of the formula S1—R—S2, where S1 and S2 are complementary and at least 15 nucleotides in length, with R being a six base recognition site for a restriction endonuclease, and varying in nucleotide sequence, along with a method for amplifying circular nucleic acids to produce shRNA for targeted gene suppression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If vector-based methods are used to deliver shRNA into cells, then gene suppression efficiency is improved, but the variability and efficiency of generating diverse shRNA libraries is limited
Solution Approach 1:
The shRNA sequence is divided into two complementary segments, S1 and S2, each at least 15 nucleotides long. These segments are designed to be complementary to each other along their entire length, allowing them to form a hairpin structure when transcribed. This segmentation enables systematic generation of diverse shRNA sequences by varying the nucleotide sequences of S1 and S2 while maintaining the complementary relationship, thereby increasing library diversity without compromising gene suppression efficiency.
Solution Approach 2:
The invention systematically varies the nucleotide sequences of S1 and S2 across different members of the shRNA library. By changing the nucleotide parameters (sequence composition, length, and arrangement) while maintaining the complementary relationship and hairpin structure, the method generates a diverse library of shRNAs with different target specificities. This parameter variation approach allows the library to cover a broad range of gene targets while each individual shRNA maintains high suppression efficiency.
2Reliability
If synthetic siRNA molecules are delivered into cells, then gene expression suppression is achieved, but the variability and efficiency of generating diverse shRNA libraries is limited
Solution Approach 1:
The shRNA vectors are designed to be transcribed within the cell by the cell's own RNA polymerase III machinery, eliminating the need for external synthetic siRNA delivery. The vector contains the necessary promoter and sequence elements to autonomously produce the shRNA sequence, which is then processed by cellular Dicer enzymes into functional siRNAs. This self-service approach dramatically improves library generation efficiency by replacing complex synthetic delivery systems with a simple viral vector-based system that leverages cellular machinery.
Solution Approach 2:
Instead of directly delivering synthetic siRNA molecules, the invention uses viral vectors to copy and replicate the shRNA coding sequence within the cell genome. The vector contains the shRNA sequence flanked by viral promoter and terminator elements, allowing the cell to transcribe and process the sequence into functional siRNAs. This copying approach enables efficient library generation by utilizing the cell's natural transcription and processing pathways rather than requiring external synthetic molecule delivery.
3Reliability
If shRNA is processed through Dicer enzymes, then functional siRNA is generated, but the complexity of the delivery and processing system increases
Solution Approach 1:
The invention exploits the cell's existing Dicer enzyme machinery to process the transcribed shRNA into functional siRNAs. The vector is designed to be transcribed by cellular RNA polymerase III, and the resulting pre-shRNA is immediately processed by cellular Dicer enzymes that are already present in the cell. This self-service approach eliminates the need for external processing systems, reducing delivery complexity while maintaining reliable shRNA processing efficiency.
Solution Approach 2:
The viral vector acts as an intermediary carrier that delivers the shRNA coding sequence into the cell without requiring direct delivery of the shRNA molecule itself. The vector contains the necessary regulatory elements (promoter, terminator) that mediate the transcription and processing of the shRNA sequence. This intermediary approach simplifies the delivery system by using the vector as a convenient carrier that leverages cellular processing machinery rather than requiring complex external delivery and processing systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach enables the production of a diverse library of shRNA vectors that can effectively target specific mRNA sequences, enhancing gene suppression efficiency and variability, suitable for applications in drug discovery and therapeutic interventions.
Implementation Method 1
an RNA polymerase III promoter, such as H1 promoter and U6 promoter is used to drive transcription of shRNA
Implementation Method 2
RNA interference (RNAi) is a mechanism that inhibits gene expression at the stage of translation or by hindering the transcription of specific genes
Implementation Method 3
Dicer is involved in the processing of the dsRNA into short pieces of dsRNA known as short inhibitory RNAs (siRNAs)
Implementation Method 4
S1 and S2 are complementary to each other along their entire length
Implementation Method 5
R is the nucleotide sequence of a six base recognition site for a restriction endonuclease
Data Source
AI summary
As noted above, certain aspects of this disclosure relate to a library of nucleic acid vectors, as well as a method for making the same. In certain embodiments, the library of nucleic acid vectors comprises: a plurality of nucleic acid molecules of the following formula: S1—R—S2 wherein, in each nucleic acid of the plurality: S1 and S2 are each at least 15 nucleotides in length; S1 and S2 are complementary to each other along their entire length; either S1 or S2 is complementary along its entire length to a sequence in eukaryotic mRNA; and R is a six base recognition site for a restriction endonuclease; and wherein S1 and S2 vary in nucleotide sequence between different members of the plurality. A method for amplifying a circular nucleic acid is also provided.